08 sep 25   templetonemerg.mkt. - kepler trust intelligence: new research templeton emerging markets investment trust plc | tem | 202 0 0.0% | mkt cap: 1,968m    rns number : 2136y templeton emerging markets it plc 08 september 2025   templeton emerging markets: new research     08/09/2025      tem has outperformed the index under chetan sehgal's stewardship. the investment companies team at kepler trust intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. this note is free to read for uk investors. click here to read the note in full.   visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.   important information this report has been issued by kepler partners llp.  the analyst who has prepared this report is aware that kepler partners llp has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research. past performance is not a reliable indicator of future results. the value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. it is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision. kepler partners is not authorised to make recommendations to retail clients. this report has been issued by kepler partners llp, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment. the information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject kepler partners llp to any registration requirement within such jurisdiction or country. in particular, this website is exclusively for non-us persons. persons who access this information are required to inform themselves and to comply with any such restrictions. the information contained in this website is not intended to constitute, and should not be construed as, investment advice. no representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. any views and opinions, whilst given in good faith, are subject to change without notice. this is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. any prices or quotations contained herein are indicative only.   kepler partners llp (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. a copy of the firm's conflict of interest policy is available on request. please see also our terms and conditions kepler partners llp is authorised and regulated by the financial conduct authority (frn 480590), registered in england and wales at 70 conduit street, london w1s 2gf with registered number oc334771. visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.   this information is provided by reach, the non-regulatory press release distribution service of rns, part of the london stock exchange. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   nraupupubupauba return to news summary

Label: Neutral